相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of depression with ketamine does not change plasma levels of brain-derived neurotrophic factor or vascular endothelial growth factor
Gustavo C. Medeiros et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
Psilocybin Therapeutic Research: The Present and Future Paradigm
Robert B. Kargbo
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Vagus nerve stimulation and Neurotrophins: a biological psychiatric perspective
Pamela Rosso et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
A critical review of the Lancet Commission on global mental health and sustainable development: Time for a paradigm change
Lisa Cosgrove et al.
CRITICAL PUBLIC HEALTH (2020)
Confusing preclinical (predictive) drug screens with animal models' of psychiatric disorders, or disorder-like' behaviour, is undermining confidence in behavioural neuroscience
S. C. Stanford
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Vagal Nerve Stimulation for Treatment-Resistant Depression
Flavia R. Carreno et al.
NEUROTHERAPEUTICS (2017)
Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
Ashley E. Lepack et al.
NEUROPHARMACOLOGY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Immobility in the forced swim test is adaptive and does not reflect depression
Marc L. Molendijk et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies
Kathryn Chapman et al.
DRUG DISCOVERY TODAY (2014)
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
C. N. Haile et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Neurobiology of Rapid Acting Antidepressants: Role of BDNF and GSK-3β
Ronald S. Duman et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Using the rat forced swim test to assess antidepressant-like activity in rodents
David A. Slattery et al.
NATURE PROTOCOLS (2012)
Revitalizing psychiatric drug discovery
Martin Sarter et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy
Megumi Adachi et al.
BIOLOGICAL PSYCHIATRY (2008)
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
Andre Russowsky Brunoni et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
A final common pathway for depression? Progress toward a general conceptual framework
Eric A. Stone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult mate rats
Gaelle Naert et al.
PSYCHONEUROENDOCRINOLOGY (2007)
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients
Luisella Bocchio-Chiavetto et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment
JF Cryan et al.
PSYCHOPHARMACOLOGY (2005)
Forced swimming test in mice: a review of antidepressant activity
B Petit-Demouliere et al.
PSYCHOPHARMACOLOGY (2005)
A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine
I Weiner et al.
BEHAVIOURAL PHARMACOLOGY (2003)
分享论文
